Neurocrine Biosciences, Inc. (NBIX)

Neurocrine Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	266.5	713	233	251.1	262.9	340.8
Short-Term Investments	1,050	767.4	843.1	780.5	726.4	370.5
Cash & Short-Term Investments	1,316	1,480	1,076	1,032	989.3	711.3
Cash Growth	39.50%	37.57%	4.31%	4.28%	39.08%	-11.20%
Accounts Receivable	768.1	686.8	479.1	439.3	350	185.5
Inventory	64.5	69	57.4	38.3	35.1	30.5
Other Current Assets	287.3	219.2	179.4	97.8	79.1	45.5
Total Current Assets	2,436	2,523	1,725	1,607	1,454	972.8
Net Property, Plant & Equipment	538	545.2	592	347.3	145.6	155.8
Other Intangible Assets	-	-	-	35.5	37.2	-
Long-Term Investments	1,477	1,184	864.3	849.4	401.5	624.4
Other Long-Term Assets	455	379.8	537.7	412.2	330.9	319.5
Total Assets	4,906	4,632	3,719	3,251	2,369	2,073
Accounts Payable	773	674.3	461.6	448.8	347.6	225.8
Current Portion of Long-Term Debt	-	-	-	170.1	169.4	-
Other Current Liabilities	58.7	69.1	46.1	35.9	20.7	20
Total Current Liabilities	831.7	743.4	507.7	654.8	537.7	245.8
Long-Term Debt	-	-	-	-	-	335.1
Long-Term Leases	406.2	415.3	455.1	258.3	93.5	105.3
Other Long-Term Liabilities	260.9	219.7	166.2	106.3	29.7	12.3
Total Long-Term Liabilities	667.1	635	621.3	364.6	123.2	452.7
Total Liabilities	1,499	1,378	1,129	1,019	660.9	698.5
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Additional Paid-in Capital	2,817	2,792	2,555	2,382	2,122	2,011
Accumulated Other Comprehensive Income	0.4	13.1	5.8	7	-7.9	-1.7
Retained Earnings	589.6	447.7	29.2	-157.1	-406.8	-635.8
Shareholders' Equity	3,407	3,253	2,590	2,232	1,708	1,374
Total Liabilities & Equity	4,906	4,632	3,719	3,251	2,369	2,073
Total Debt	406.2	415.3	455.1	428.4	262.9	440.4
Net Cash (Debt)	910	1,065	621	603.2	726.4	270.9
Net Cash Growth	-14.56%	71.51%	2.95%	-16.96%	168.14%	-30.31%
Net Cash Per Share	8.87	10.39	5.99	5.97	7.34	2.77
Book Value	3,407	3,253	2,590	2,232	1,708	1,374
Book Value Per Share	33.19	31.74	24.97	22.10	17.27	14.03
Tangible Book Value	3,407	3,253	2,590	2,197	1,671	1,374
Tangible Book Value Per Share	33.19	31.74	24.97	21.75	16.89	14.03

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q